Your browser doesn't support javascript.
loading
An international multicenter cohort study on implantable cardioverter-defibrillators for the treatment of symptomatic children with catecholaminergic polymorphic ventricular tachycardia.
Lamba, Avani; Roston, Thomas M; Peltenburg, Puck J; Kallas, Dania; Franciosi, Sonia; Lieve, Krystien V V; Kannankeril, Prince J; Horie, Minoru; Ohno, Seiko; Brugada, Ramon; Aiba, Takeshi; Fischbach, Peter; Knight, Linda; Till, Jan; Kwok, Sit-Yee; Probst, Vincent; Backhoff, David; LaPage, Martin J; Batra, Anjan S; Drago, Fabrizio; Haugaa, Kristina; Krahn, Andrew D; Robyns, Tomas; Swan, Heikki; Tavacova, Terezia; van der Werf, Christian; Atallah, Joseph; Borggrefe, Martin; Rudic, Boris; Sarquella-Brugada, Georgia; Chorin, Ehud; Hill, Allison; Kammeraad, Janneke; Kamp, Anna; Law, Ian; Perry, James; Roberts, Jason D; Tisma-Dupanovic, Svjetlana; Semsarian, Christopher; Skinner, Jonathan R; Tfelt-Hansen, Jacob; Denjoy, Isabelle; Leenhardt, Antoine; Schwartz, Peter J; Ackerman, Michael J; Blom, Nico A; Wilde, Arthur A M; Sanatani, Shubhayan.
Afiliação
  • Lamba A; BC Children's Hospital, Division of Cardiology, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Roston TM; BC Children's Hospital, Division of Cardiology, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada; Center for Cardiovascular Innovation, Division of Cardiology, The University of British Columbia, Vancouver, Canada.
  • Peltenburg PJ; Amsterdam UMC, University of Amsterdam, Heart Centre, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands; Department of Pediatric Cardiology, Amsterdam UMC, University of Amsterdam, Emma Children's Hospital
  • Kallas D; BC Children's Hospital, Division of Cardiology, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Franciosi S; BC Children's Hospital, Division of Cardiology, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada.
  • Lieve KVV; Amsterdam UMC, University of Amsterdam, Heart Centre, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands.
  • Kannankeril PJ; Department of Pediatrics, Monroe Carell Jr Children's Hospital at Vanderbilt, Vanderbilt University Medical Centre, Nashville, Tennessee.
  • Horie M; Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan.
  • Ohno S; Department of Cardiovascular Medicine, Shiga University of Medical Science, Otsu, Japan; Department of Bioscience and Genetics, National Cerebral and Cardiovascular Centre, National Cerebral and Cardiovascular Centre, Suita, Japan.
  • Brugada R; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain; Cardiovascular Genetics Center, Institut d'Investigació Biomèdica Girona (IDIBGI), University of Girona, Girona, Spain; Medical Science Department, School of Medicine, University of Girona, Girona, Sp
  • Aiba T; Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Centre, Suita, Japan.
  • Fischbach P; Sibley Heart Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Knight L; Sibley Heart Center, Children's Healthcare of Atlanta, Atlanta, Georgia.
  • Till J; Department of Cardiology, Royal Brompton Hospital, London, UK.
  • Kwok SY; Hong Kong Children's Hospital, Hong Kong, SAR China.
  • Probst V; Université de Nantes, CHU Nantes, CNRS, INSERM, l'institut du thorax, Nantes, France.
  • Backhoff D; University of Gottingen, Gottingen, Germany.
  • LaPage MJ; University of Michigan, Ann Arbor, Michigan.
  • Batra AS; Division of Cardiology, Department of Pediatrics, Irvine and Children's Hospital of Orange County, University of California, Orange, California.
  • Drago F; Pediatric Cardiology and Cardiac Arrhythmias Unit, Department of Pediatric Cardiology and Cardiac Surgery, Bambino Gesù Children's Hospital, IRCCS, Palidoro-Rome, Italy.
  • Haugaa K; ProCardio Center for Innovation, Department of Cardiology, Oslo University Hospital, Rikshospitalet, Oslo, Norway; and Department of Cardiology, Karolinska University Hospital, and Department of Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden.
  • Krahn AD; Center for Cardiovascular Innovation, Division of Cardiology, The University of British Columbia, Vancouver, Canada.
  • Robyns T; Department of Cardiovascular Diseases, University Hospitals Leuven, Belgium; Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
  • Swan H; Heart and Lung Centre, Helsinki University Hospital and Helsinki University, Helsinki, Finland.
  • Tavacova T; Department of Pediatric Cardiology, Children's Heart Centre, Second Faculty of Medicine, Charles University in Prague, Motol University Hospital, Prague, Czech Republic.
  • van der Werf C; Amsterdam UMC, University of Amsterdam, Heart Centre, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands.
  • Atallah J; Cardiology, Faculty of Medicine & Dentistry - Pediatrics Dept., Stollery Children's Hospital, Edmonton, Canada.
  • Borggrefe M; Department of Medicine, University Medical Center Mannheim, Mannheim, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Mannheim, Germany.
  • Rudic B; Department of Medicine, University Medical Center Mannheim, Mannheim, Germany; German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg, Mannheim, Germany.
  • Sarquella-Brugada G; Pediatric Arrhythmias, Inherited Cardiac Diseases and Sudden Death Unit, Hospital Sant Joan de Déu, Spain; Medical Science Department, School of Medicine, Universitat de Girona, Girona, Spain.
  • Chorin E; Department of Cardiology, Tel Aviv Sourasky Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Hill A; Children's Hospital Los Angeles, Los Angeles, California.
  • Kammeraad J; Department of Pediatric Cardiology, Erasmus MC - Sophia, Rotterdam, The Netherlands.
  • Kamp A; Nationwide Children's Hospital, Columbus, Ohio.
  • Law I; University of Iowa Stead Family Children's Hospital, Iowa City, Iowa.
  • Perry J; Rady Children's Hospital, San Diego, California.
  • Roberts JD; Section of Cardiac Electrophysiology, Division of Cardiology, Department of Medicine, Western University, London, Ontario, Canada; Population Health Research Institute, Hamilton Health Sciences, and McMaster University, Hamilton, Ontario, Canada.
  • Tisma-Dupanovic S; Nemours Children's Clinic, Orlando, Florida.
  • Semsarian C; Agnes Ginges Centre for Molecular Cardiology at Centenary Institute, The University of Sydney, Sydney, Australia; Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
  • Skinner JR; Cardiac Inherited Disease Group New Zealand, Green Lane Paediatric and Congenital Cardiac Services, Starship Children's Hospital, Auckland, New Zealand; Department of Paediatrics Child and Youth Health, The University of Auckland, Auckland, New Zealand.
  • Tfelt-Hansen J; Department of Cardiology, Rigshospitalet, Department of Forensic Medicine, Faculty of Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Denjoy I; Service de Cardiologie et CNMR Maladies Cardiaques Héréditaires Rares, Hôpital Bichat, APHP, Université de Paris Cité, Paris, France.
  • Leenhardt A; Service de Cardiologie et CNMR Maladies Cardiaques Héréditaires Rares, Hôpital Bichat, APHP, Université de Paris Cité, Paris, France.
  • Schwartz PJ; Istituto Auxologico Italiano, IRCCS, Center for Cardiac Arrhythmias of Genetic Origin, Milan, Italy.
  • Ackerman MJ; Departments of Cardiovascular Medicine, Pediatric and Adolescent Medicine, and Molecular Pharmacology & Experimental Therapeutics; Division of Heart Rhythm Services and Pediatric Cardiology, Windland Smith Rice Sudden Death Genomics Laboratory, Mayo Clinic, Rochester, Minnesota.
  • Blom NA; Department of Pediatric Cardiology, Amsterdam UMC, University of Amsterdam, Emma Children's Hospital, Amsterdam, The Netherlands; Department of Pediatric Cardiology, Willem-Alexander Children's Hospital, Leiden University Medical Centre, Leiden, The Netherlands.
  • Wilde AAM; Amsterdam UMC, University of Amsterdam, Heart Centre, Department of Clinical and Experimental Cardiology, Amsterdam Cardiovascular Sciences, Heart Failure and Arrhythmias, Amsterdam, the Netherlands.
  • Sanatani S; BC Children's Hospital, Division of Cardiology, Department of Pediatrics, The University of British Columbia, Vancouver, British Columbia, Canada. Electronic address: ssanatani@cw.bc.ca.
Heart Rhythm ; 2024 Apr 07.
Article em En | MEDLINE | ID: mdl-38588993
ABSTRACT

BACKGROUND:

Catecholaminergic polymorphic ventricular tachycardia (CPVT) may cause sudden cardiac death (SCD) despite medical therapy. Therefore, implantable cardioverter-defibrillators (ICDs) are commonly advised. However, there is limited data on the outcomes of ICD use in children.

OBJECTIVE:

The purpose of this study was to compare the risk of arrhythmic events in pediatric patients with CPVT with and without an ICD.

METHODS:

We compared the risk of SCD in patients with RYR2 (ryanodine receptor 2) variants and phenotype-positive symptomatic CPVT patients with and without an ICD who were younger than 19 years and had no history of sudden cardiac arrest at phenotype diagnosis. The primary outcome was SCD; secondary outcomes were composite end points of SCD, sudden cardiac arrest, or appropriate ICD shocks with or without arrhythmic syncope.

RESULTS:

The study included 235 patients, 73 with an ICD (31.1%) and 162 without an ICD (68.9%). Over a median follow-up of 8.0 years (interquartile range 4.3-13.4 years), SCD occurred in 7 patients (3.0%), of whom 4 (57.1%) were noncompliant with medications and none had an ICD. Patients with ICD had a higher risk of both secondary composite outcomes (without syncope hazard ratio 5.85; 95% confidence interval 3.40-10.09; P < .0001; with syncope hazard ratio 2.55; 95% confidence interval 1.50-4.34; P = .0005). Thirty-one patients with ICD (42.5%) experienced appropriate shocks, 18 (24.7%) inappropriate shocks, and 21 (28.8%) device-related complications.

CONCLUSION:

SCD events occurred only in patients without an ICD and mostly in those not on optimal medical therapy. Patients with an ICD had a high risk of appropriate and inappropriate shocks, which may be reduced with appropriate device programming. Severe ICD complications were common, and risks vs benefits of ICDs need to be considered.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article